Raleigh Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $316K | Sell |
3,627
-221
| -6% | -$19.3K | 0.13% | 166 |
|
|
2025
Q1 | $346K | Sell |
3,848
-280
| -7% | -$25.2K | 0.16% | 146 |
|
|
2024
Q4 | $330K | Sell |
4,128
-64
| -2% | -$5.11K | 0.13% | 160 |
|
|
2024
Q3 | $377K | Sell |
4,192
-674
| -14% | -$60.7K | 0.15% | 150 |
|
|
2024
Q2 | $383K | Buy |
4,866
+272
| +6% | +$21.4K | 0.16% | 136 |
|
|
2024
Q1 | $400K | Sell |
4,594
-13,864
| -75% | -$1.21M | 0.17% | 138 |
|
|
2023
Q4 | $1.52M | Sell |
18,458
-678
| -4% | -$55.9K | 0.71% | 43 |
|
|
2023
Q3 | $1.5M | Buy |
19,136
+2,161
| +13% | +$169K | 0.76% | 42 |
|
|
2023
Q2 | $1.5M | Sell |
16,975
-1,370
| -7% | -$121K | 0.75% | 44 |
|
|
2023
Q1 | $1.48M | Buy |
18,345
+758
| +4% | +$61.1K | 0.73% | 43 |
|
|
2022
Q4 | $1.37M | Buy |
17,587
+12,644
| +256% | +$983K | 0.71% | 43 |
|
|
2022
Q3 | $399K | Buy |
4,943
+357
| +8% | +$28.8K | 0.23% | 114 |
|
|
2022
Q2 | $412K | Buy |
4,586
+242
| +6% | +$21.7K | 0.23% | 109 |
|
|
2022
Q1 | $482K | Buy |
4,344
+1,103
| +34% | +$122K | 0.26% | 106 |
|
|
2021
Q4 | $335K | Buy |
+3,241
| New | +$335K | 0.34% | 71 |
|